The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease

The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease

The number of allogeneic hematopoietic stem cell transplantations conducted worldwide is constantly rising. Together with that, the absolute number of complications after the procedure is increasing, with graft-versus-host disease (GvHD) being one of the most common. The standard treatment is steroi...

Full description

Bibliographic Details
Main Authors:	Jarosław Biliński, Marcin Jasiński, Grzegorz W. Basak
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Biomedicines
Subjects:	gut microbiota graft-versus-host disease fecal microbiota transplantation gut-immune cells cross-talk gastrointestinal acute GvHD
Online Access:	https://www.mdpi.com/2227-9059/10/4/837

Similar Items

THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
by: Lucrezia Laterza, et al.
Published: (2016-05-01)

Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) – Case series
by: Ashley N. Gray, et al.
Published: (2023-05-01)

Longitudinal dynamics of gut microbiota in the pathogenesis of acute graft‐versus‐host disease
by: Ling Qi, et al.
Published: (2023-12-01)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
by: Yannouck F. van Lier, et al.
Published: (2023-12-01)

Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
by: Roni Shouval, et al.
Published: (2019-04-01)

Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
by: Anna Cäcilia Ingham, et al.
Published: (2021-06-01)

Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
by: XiaoYan Yue, et al.
Published: (2024-02-01)

Janus kinase inhibition in the treatment and prevention of graft-versus-host disease
by: Elisa De Togni, et al.
Published: (2024-02-01)

Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
by: M. Faraci, et al.
Published: (2024-03-01)

Established and Emerging Treatments of Skin GvHD
by: Cornelia S. Link-Rachner, et al.
Published: (2022-02-01)

Fecal Microbiota Transplantation in Autism Spectrum Disorder
by: Li Y, et al.
Published: (2022-12-01)

Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial
by: Ye Zhao, et al.
Published: (2021-06-01)

Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease—an analysis from transplant centers across Europe
by: Ronja Langer, et al.
Published: (2024-03-01)

Fecal microbiota transplantation in the obesity treatment – a literature review
by: Monika Sroczyńska, et al.
Published: (2023-01-01)

From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease
by: Rachel Limpert, et al.
Published: (2023-06-01)

A Systematic Review of Current Applications of Fecal Microbiota Transplantation in Horses
by: Maimaiti Tuniyazi, et al.
Published: (2023-04-01)

Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review
by: Andrea Pession, et al.
Published: (2021-02-01)

Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report
by: Shuwen Zhong, et al.
Published: (2019-08-01)

Graft-versus-Host Disease Modulation by Innate T Cells
by: Ying Fang, et al.
Published: (2023-02-01)

Gut Microbiota and Fecal Microbiota Transplantation in Patients with Food Allergies: A Systematic Review
by: Caroline Jensen, et al.
Published: (2022-09-01)

Novel therapies for graft versus host disease with a focus on cell therapies
by: Robert Zeiser, et al.
Published: (2023-10-01)

Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward
by: Shaghayegh Habibi, et al.
Published: (2023-12-01)

Graft versus host disease occurring in living donor liver transplant
by: Nalini Bansal, et al.
Published: (2018-01-01)

Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study
by: Mariella Lo Schirico, et al.
Published: (2023-05-01)

ORAL GRAFT VERSUS HOST DISEASE: A REVIEW
by: Reddy Lavanya, et al.
Published: (2016-03-01)

Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review
by: Abhinav Bhattarai, et al.
Published: (2024-12-01)

From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
by: Carole Nicco, et al.
Published: (2020-04-01)

Fresh Versus Frozen Stool for Fecal Microbiota Transplantation—Assessment by Multimethod Approach Combining Culturing, Flow Cytometry, and Next-Generation Sequencing
by: Jaroslaw Bilinski, et al.
Published: (2022-07-01)

Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
by: Olle Ringdén, et al.
Published: (2022-03-01)

Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
by: Cátia Almeida, et al.
Published: (2022-10-01)

A brief account on ocular graft versus host disease
by: Debapriya Chatterjee
Published: (2023-01-01)

Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety
by: O. V. Goloshchapov, et al.
Published: (2020-09-01)

Hyperacute graft-versus-host disease of the skin following allogeneic stem cell transplantation: A paediatric case series
by: Gauri D Mahabal, et al.
Published: (2023-01-01)

Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
by: Kilian Kelly, et al.
Published: (2021-10-01)

Fecal Microbiota Transplantation Donor and Dietary Fiber Intervention Collectively Contribute to Gut Health in a Mouse Model
by: Yifan Zhong, et al.
Published: (2022-02-01)

Complex interactions of cellular players in chronic Graft-versus-Host Disease
by: Laura Marie Gail, et al.
Published: (2023-06-01)

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
by: Hui Xu, et al.
Published: (2022-09-01)

Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives
by: Mattia Paratore, et al.
Published: (2021-06-01)

The Potential Role of Fecal Microbiota Transplantation in Parkinson’s Disease: A Systematic Literature Review
by: Tahne Vongsavath, et al.
Published: (2023-08-01)

Fecal Microbiota Transplantation in Liver Diseases and Recent Developments
by: Mohammad Hossein somi, et al.
Published: (2022-12-01)